Canntab Therapeutics (STU:TBF1) Market Cap : €0.13 Mil (As of Jun. 22, 2024)

Canntab Therapeutics Market Cap Chart

Canntab Therapeutics Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	May17	May18	May19	May20	May21	May22
Market Cap		Get a 7-Day Free Trial					-	11.64	19.98	23.54	7.59

Canntab Therapeutics Quarterly Data
	Mar18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
Market Cap	Get a 7-Day Free Trial															16.95	7.59	7.16	7.16	7.16

Competitive Comparison of Canntab Therapeutics's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Canntab Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Canntab Therapeutics's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canntab Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Canntab Therapeutics's Market Cap falls into.

Canntab Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Canntab Therapeutics's Market Cap for the fiscal year that ended in May. 2022 is calculated as

Canntab Therapeutics's Market Cap for the quarter that ended in Feb. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canntab Therapeutics  (STU:TBF1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Canntab Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Canntab Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Canntab Therapeutics (STU:TBF1) Business Description